Latest News

UN drugs body approves controls on deadly opioid

Wednesday, March 14, 2018

Print this page Email A Friend!

VIENNA, Austria (AFP) — A UN's anti-drug body added carfentanil, a synthetic substance estimated to be thousands of times more potent than morphine, to its list of controlled substances on Wednesday.

The US had been pushing for the move, and welcomed the decision the UN's Commission on Narcotic Drugs' (CND) unanimous vote.

Carfentanil is one of the substances the United States is trying to crack down on to combat its opioid epidemic, which health officials warned earlier this month was accelerating.

The CND's decision follows the scheduling of a similar drug, fentanyl, last year.

By scheduling substances, the CND requires countries to regulate their production, sale and export.

US officials say that the decision to schedule fentanyl has helped them to better cooperate with other countries to combat the trade over the past year.

An estimated 2.4 million Americans are addicted to opiates, the narcotics that include prescription painkillers, as well as heroin.

Last year President Donald Trump declared the opioid crisis a national public health emergency.

Deaths from opioid overdoses have also been recorded in Canada, Europe, Australia and North Africa.




1. We welcome reader comments on the top stories of the day. Some comments may be republished on the website or in the newspaper � email addresses will not be published.

2. Please understand that comments are moderated and it is not always possible to publish all that have been submitted. We will, however, try to publish comments that are representative of all received.

3. We ask that comments are civil and free of libellous or hateful material. Also please stick to the topic under discussion.

4. Please do not write in block capitals since this makes your comment hard to read.

5. Please don't use the comments to advertise. However, our advertising department can be more than accommodating if emailed:

6. If readers wish to report offensive comments, suggest a correction or share a story then please email:

7. Lastly, read our Terms and Conditions and Privacy Policy

comments powered by Disqus



Today's Cartoon

Click image to view full size editorial cartoon